Endocrinology Vol. 138, No. 2 553-559
Copyright © 1997 by The Endocrine Society
Androgen Modulation of the Messenger Ribonucleic Acid of Retinoic Acid Receptors in the Prostate, Seminal Vesicles, and Kidney in the Rat1
Hosea F. S. Huang,
Ming-tang Li,
Stanley Von Hagen,
Yuan Fang Zhang2 and
Robert J. Irwin
Department of Surgery, Section of Urology (H.F.S.H., M.T.L.,
R.J.I.), Department of Pharmacology, Physiology, and Toxicology
(S.V.H.), and Preventive Medicine and Community Health Biostatistics
Division (S.V.H.), University of Medicine and Dentistry of New Jersey
Medical School, Newark, New Jersey 07103; and the Veterans Affair
Medical Center (H.F.S.H.), East Orange, New Jersey 07019
Address all correspondence and requests for reprints to: Dr. Hosea F. S. Huang, Department of Surgery Section of Urology, University of Medicine and Dentistry of New Jersey Medical School, 185 South Orange Avenue, Newark, New Jersey 07103.
 |
Abstract
|
|---|
Previously, we reported that the steady state level of messenger RNA
(mRNA) transcripts of retinoic acid receptors (RAR)
and
in the
testes of 20-day-old rats can be modulated by exogenous testosterone.
These results suggest that androgen regulation of Sertoli cell
functions may involve biochemical events mediated by RAR genes. In this
study, we examined the effects of castration and testosterone
replacement on the steady state level of mRNA transcripts for RAR
and
in the prostate, seminal vesicles, and kidney of the rat.
Northern blot analysis revealed that in intact adult rats, the relative
steady state levels of the 3.4- and 2.7-kilobase (kb) mRNA transcripts
for RAR
and the 3.4-kb transcript for RAR
in the prostate were at
least 20-fold higher than those in the seminal vesicles and kidney. The
relatively high abundance of RAR mRNA transcripts in the prostate
suggests the physiological importance of RAR-mediated processes in this
organ. Castration resulted in an increase in the level of RAR mRNA
transcripts in the prostate and seminal vesicles, reaching a maximum of
2- to 4-fold in the prostate and 15- to 23-fold in the seminal vesicles
within 6 days. On the other hand, the levels of mRNA transcripts of
RAR
and -
in the kidney were reduced by 4050% 1 day after
castration. The effects of castration on RAR mRNA levels in all three
organs were prevented by implantation of 3-cm testosterone capsules at
the time of castration, a regimen that provides physiological levels of
serum testosterone.
In a subsequent experiment, adult male rats were given a single sc
injection of 2 mg testosterone 3 days after castration. This treatment
resulted in an acute suppression of the level of RAR mRNA transcripts
in all three organs within 30 min. Thereafter, the levels of RAR
and
-
mRNA transcripts in the prostate continued to decrease, whereas
those in the seminal vesicles returned to the castrated levels within
6 h. On the other hand, RAR mRNA levels in the kidney rebounded by
1 h and remained at the level found in the untreated castrated
rats.
These results demonstrate that the steady state level of mRNA
transcripts for RAR
and -
in the prostate, seminal vesicles, and
kidney can be modulated by testosterone in organ-specific manners, thus
suggesting that the RAR-mediated processes may be involved in the
effects of androgen in these organs. Furthermore, the relatively low
increment in prostatic RAR mRNA levels after castration compared to
that in the seminal vesicles demonstrates a difference in androgen
responses between these two organs. This difference could dictate the
efficacy of the effects of androgen on cellular function and may
contribute to the disparate vulnerabilities to androgen-related
uncontrolled cell proliferation and/or malignancy in the prostate and
seminal vesicles.
 |
Introduction
|
|---|
THE DEVELOPMENT and function of male
accessory glands, the prostate and seminal vesicles, are well
documented androgen-dependent processes. Androgen ablation results in a
decrease in overall cellular activities and an increase in cell death,
leading to the regression of these organs (1, 2, 3, 4). In addition to these
male accessory organs, the presence of androgen receptor and androgen
modulation of cellular activities have been reported in many other
organs, including the kidney, even though these organs do not require
androgen for normal function (5, 6). Androgen exerts its biological
effects by binding to the nuclear androgen receptor in target cells.
The cascade of biochemical events initiated by this ligand-receptor
interaction is, in turn, responsible for numerous changes in cellular
activities (7, 8). Differences in post-receptor events are probably
responsible for the varying effects of androgen in different organs.
Thus, identification of an androgen-responsive gene(s) and the
molecular events elicited by these genes may provide a new
understanding of the mode of androgen actions in different organs.
Recently, Huang et al. (9) reported that administration of a
single dose of 1 mg testosterone to 20-day-old rats resulted in acute,
but diverse, responses of the steady state levels of messenger RNA
(mRNA) for retinoic acid receptors (RAR)
and
in the testis.
This observation demonstrated that the RAR genes can be modulated by
androgen and suggests that RAR-mediated processes may be involved in
the androgen regulation of Sertoli cell functions.
RARs are important in mediating the biological actions of retinoic acid
that are essential for normal cell proliferation, differentiation, and
development (10, 11, 12). Therefore, understanding the effects of androgen
on the expression of RAR genes in organs in which cell proliferation
and functions are sensitive to androgen manipulation and also in organs
that are independent of androgen for normal function may provide new
insights into the mechanisms that determine the cellular effects of
androgen in different organs. In this study, we examined the effects of
castration and testosterone replacement on the expression of mRNA for
RAR
and -
in the prostate, seminal vesicles, and kidney of adult
rats.
 |
Materials and Methods
|
|---|
Animals
Adult Sprague-Dawley rats (300350 g; Toconic Farm, Toconic,
NY) were maintained in an air-conditioned and light-controlled animal
room for 2 weeks before the experiment. Animals were fed Purina rat
chow (Ralston Purina, St. Louis, MO) and water ad
libitum.
Exp 1.
Animals were lightly anesthetized with ether, and
both testes were removed surgically through a midscrotal incision.
Animals were killed 16 days after castration. In some animals (n
= 4), a 3-cm testosterone capsule was implanted sc on the back
immediately after castration. These animals were also killed 6 days
later. The prostate gland, seminal vesicles, and kidney were dissected
on an ice-cold petri dish, frozen on dry ice, and stored at -80 C for
subsequent analysis.
Exp 2.
Castrated male rats were given a single sc injection
of 2 mg testosterone 3 days after castration. Animals were killed
0.56 h later. The prostate gland, seminal vesicles, and kidney were
dissected, frozen, and stored at -80 C.
RNA isolation and Northern blot hybridization
Total RNA were isolated from different tissues by the single
step method described by Chomczynski and Sacchi (13). Tissues were
homogenized with a Polytron homogenizer (Brinkmann Instruments,
Westbury, NY) in 5 vol denaturing solution containing 4 M
guanidine thiocyanate; 25 mM sodium citrate, pH 7.0; 0.5%
sarcosyl; and 0.1 M 2-mercaptoethanol. After the phenol and
chloroform-isoamyl alcohol extraction, the RNA in the aqueous phase was
precipitated with 1 vol isopropanol at -20 C overnight and dried under
a vacuum. The polyadenylated [poly(A)+] RNAs were
subsequently isolated by oligo(deoxythymidine)-cellulose chromatography
(14), separated electrophoretically on a 1% agarose-17% formaldehyde
gel (15), and blotted onto a Biotrans membrane (ICN Biomedical, Costa
Mesa, CA). The complementary DNA (cDNA) probes of mouse RAR
, -ß,
and -
(16, 17) were isolated by agarose electrophoresis after
appropriate endonucleases digestion and radiolabeled with
[32P]deoxy-CTP, using a random priming kit (Boehringer
Mannheim, Indianapolis, IN). The blots were prehybridized for 24 h in
a solution containing 6 x SSC (150 mM NaCl and 15
mM sodium citrate, pH 7.0), 0.5% SDS, 50% formamide, and
100 µg/ml denatured sperm DNA at 42 C, then hybridized overnight in
the same buffer containing approximately 106 cpm/ml
radiolabeled cDNA probe. The membranes were washed in 1 x SSC
solution containing 0.1% SDS at 68 C for 2030 min, followed by
several changes in 0.2 x SSC and 0.1% SDS at 68 C for 24 h.
After exposure to Kodak XAR-5 film (Eastman Kodak, Rochester, NY) with
an intensifying screen for 210 days, the radioautographs were
developed. The membranes were subsequently stripped and rehybridized
with 32P-labeled ß-actin cDNA and/or cDNA for 18S
ribosomal RNA.
The relative abundance of different transcripts [RAR
, 3.4 and 2.7
kilobases (kb); RAR
, 3.4 kb; 18S ribosomal RNA] were estimated by
densitometric scanning by means of a Shimadzu densitometer and
integrator (Shimadzu Scientific Instruments, Princeton, NJ). Because
castration resulted in an increase in the steady state level of
ß-actin mRNA (data not shown), the steady state level of each mRNA
transcript of RAR
or -
, as estimated by the area under the curve,
was normalized against that of the 18S ribosomal RNA in each sample.
The ratio between the RAR mRNA and the 18S ribosomal RNA of the normal
control in each blot was considered 100%, and results of experimental
samples were expressed as the percentage of normal control animals in
each blot.
Statistics
ANOVA was employed to detect the effects of castration and
testosterone replacement on the RAR mRNA levels within each organ,
using the JMP statistical software package (SAS Institute, Cary, NC).
Subsequently, Dunnetts multiple range test was used to compare the
means of the castrated rats and the normal controls or the means of the
testosterone-replaced castrated rats and the untreated castrated
animals. When the 95% confident level of the experimental samples did
not overlap with 100%, the mean of that experimental group was said to
be statistically different from the control mean.
 |
Results
|
|---|
Organ distribution of RAR mRNA
Figure 1
shows the Northern blot analysis of organ
distribution of RAR
and -
mRNA in intact adult rats. The steady
state levels of the 3.4- and 2.7-kb mRNA transcripts of RAR
and the
3.4-kb RAR
mRNA in the prostate were estimated to be at least
20-fold higher than those in the seminal vesicles, kidney, and spleen.
Although the level of RAR
mRNA transcripts in the prostate was
comparable to that in the testis, the 3.4-kb RAR
mRNA was at least
20-fold higher than that in the testis. Attempts have also been made to
measure RARß mRNA, but the results were inconclusive due to very weak
signal of RARß, high background of the radiographs after prolonged
exposure, and, frequently, inconsistency among replicates.
Castration effect on RAR mRNA
Castration resulted in an increase in the levels of the 3.4- and
2.7-kb transcripts of RAR
and the 3.4-kb transcript for RAR
in
the prostate by more than 80% 1 day after castration
(P < 0.05; Table 1
) and continued to
increase to a maximum of 2- to 4-fold within 36 days (Fig. 2
). Implantation of a 3-cm testosterone capsule, a
regimen that restores normal serum testosterone levels (18), prevented
the castration-induced increases in mRNA levels of both RAR
and
-
.
The steady state levels of mRNA transcripts for RAR
and -
in the
seminal vesicles were also increased by 2- to 5-fold 1 day after
castration (P < 0.05; Fig. 3
and Table 1
) and continued to increase to 15- to 24-fold above those of the
normal controls within 6 days. Although such an increase was also
attenuated by exogenous testosterone, the levels of RAR
mRNA
transcripts in the seminal vesicles of testosterone-implanted castrated
rats remained 2- to 7-fold above those of the normal controls
(P < 0.05).
On the other hand, there was a 4050% decrease in the levels of the
mRNA transcripts of both RAR
and -
in the kidney 1 day after
castration (P < 0.05; Fig. 4
); this
effect tended to continue, but the decline was not statistically
significant (P > 0.10). Although the effect of
castration on renal RAR mRNA transcripts was also attenuated by
exogenous testosterone, RAR mRNA levels in the kidney of
testosterone-implanted rats remained lower than those in the normal
controls (P < 0.05; Table 1
).
Acute effect of testosterone on RAR mRNA in castrated rats
Administration of 2 mg exogenous testosterone to 3 day
postcastrated rats resulted in a 2030% decrease in the steady state
level of mRNA transcripts for RAR
and -
in the prostate within 30
min (P < 0.05; Fig. 5
and Table 2
). This effect continued at least 6 h after
testosterone administration. The level of mRNA for RAR
and -
in
the seminal vesicles of the castrated rats also decreased after
testosterone injection, but had rebounded by 6 h (Table 2
).
View this table:
[in this window]
[in a new window]
|
Table 2. Quantitative analysis of the effects of testosterone
replacement on the steady state level of RAR mRNA transcripts in
castrated rats
|
|
The levels of RAR mRNAs in the kidney of castrated rats decreased
acutely within 30 min after the administration of testosterone (Fig. 6
). Although RAR
and -
mRNA in the kidney
rebounded to a level above that in the untreated castrated rats by
1 h (P < 0.05; Table 2
), they remained at the
castrated levels 36 h after testosterone treatment.
 |
Discussion
|
|---|
RARs are members of the steroid-thyroid hormone receptor
superfamily, which are ligand-induced transcriptional activators (19, 20). Binding of retinoic acid to RAR initiates a cascade of biochemical
events, leading to changes in cellular activities (21, 22). Each RAR
binds to retinoic acid with a different affinity and is expressed
disparately during differentiation and development (12, 23), suggesting
that each RAR may have a specific and unique role in the regulation of
these processes. Furthermore, the presence of various mRNA transcripts
for each RAR (24, 25) leads to the postulate that isoforms of RAR
proteins, encoded by these transcripts, may mediate distinct retinoic
acid effects on cellular activities. These ideas are supported by the
recent observations of lethality and/or multiple abnormalities at
various stages of organogenesis in RAR mutant mice (12, 26).
The results of the current experiments demonstrated that under normal
physiological conditions, the steady state level of mRNA transcripts
for RAR
and -
in the prostate of adult rats was at least 20-fold
higher than those in the seminal vesicles, kidney, and spleen. Although
the relative abundance of RAR
mRNA in the prostate was comparable to
that in the testis, the level of 3.4-kb RAR
mRNA was 20-fold higher
than that in the testis. These results suggest that RAR
and -
may
have important roles in prostate physiology. An increase in the level
of RAR mRNA after castration and an acute suppression of RAR mRNA by
testosterone in both the prostate and seminal vesicles of castrated
animals demonstrate a down-regulation of RAR genes by testosterone in
these two androgen-dependent organs. These results are consistent with
our earlier observation of testosterone modulation of RAR
and -
mRNA transcripts in the testes of prepubertal rats (9) and suggest that
retinoic acid/RAR-mediated processes may be involved in testosterone
regulation of the prostate and seminal vesicles. However, the increment
in RAR mRNA levels in the prostate after castration was 6- to 8-fold
lower than that in the seminal vesicles. Furthermore, in castrated
rats, the extent and pattern of acute effects of testosterone on RAR
mRNA levels were also different between the prostate and seminal
vesicle. As the same ligand-receptor pathway is involved in
testosterone regulation of the prostate and seminal vesicles (5, 6, 27), and autoregulation of androgen receptors by androgen is also
comparable in these two organs (27, 28), variations in the sensitivity
of RAR genes to testosterone or in signal transduction pathways during
postreceptor events may be responsible for the differences. Failure to
obtain conclusive results in RARß mRNA levels, both under normal
physiological condition and after castration, may be attributable to
multiple factors. Among these is the loss of mRNA transcripts as the
result of repeated washing, as all of the membranes have been
hybridized with at least three different probes.
Previously, it was reported that mRNA transcripts of a number of renal
proteins, including alcohol dehydrogenase, ornithine decarboxylase,
ß-glucuronidase, and others, were up-regulated by androgen (6, 29, 30). Current observations of a decrease in levels of RAR
and -
mRNA in the kidney after castration and prevention of such a decrease
by a physiological dose of exogenous testosterone suggest that the RAR
genes in the kidney may also be up-regulated by androgen. The lack of a
consistent increase in renal RAR
and -
mRNA levels in castrated
rats after testosterone administration perhaps can be explained by a
delayed response of renal cells to androgen, as an increase in mRNA
levels for ornithine decarboxylase and S-adenosylmethionine
decarboxylase in castrated rats and mice did not occur until at least
68 h after the administration of testosterone (29). It is worth
noting that renal RAR mRNA levels also decreased acutely within 30 min
after testosterone administration. Because the half-life of RAR mRNA
transcripts was estimated to be approximately 12 h (31), the acute
decrease in renal RAR mRNA levels as well as those in the prostate and
seminal vesicles immediately after testosterone administration may have
resulted from an increase in mRNA degradation. A decreased
S-adenosylmethionine decarboxylase mRNA level preceding
testosterone stimulation of the same gene has been noted in the kidney
of castrated rats and mice (29). The following organ-specific changes
in RAR mRNA levels may thus reflect differences in transcriptional
regulation of RAR genes among organs. The up-regulation of renal RAR
mRNAs by testosterone, as opposed to down-regulation of the same genes
in the prostate and seminal vesicles, may contribute in part to their
difference in androgen dependency.
The regulation of RAR mRNA expression has been examined in a number of
tissues and cell types. In the testis, the steady state level of RAR
mRNAs decreases during vitamin A deficiency, but can be stimulated by
retinoic acid or retinol (32, 33, 34). In human hepatoma cells, mRNA
transcripts for RARß were reported to be transcriptionally stimulated
by retinoic acid, whereas RAR
mRNAs were not (35). In F-9 embryonic
carcinoma cells, RARß mRNA transcripts were also reported to be
stimulated by retinoic acid, but those of RAR
and -
did not
respond to the same retinoic acid regimens (31, 36). In P-19 embryonic
carcinoma cells, both RAR
and -ß mRNA transcripts were reported to
be stimulated by retinoic acid, but with a different time course of
effects (37, 38). The effects of retinoic acid on RARß mRNA
transcripts are attributable to the activation of the RARß gene that
contains the retinoic acid response element on the promoter region (39, 40). On the other hand, the level of mRNA transcripts for RAR
, -ß,
and -
in F9 embryonic carcinoma cells was reported to be suppressed
by cAMP and/or its analog, and the presence of retinoic acid was
required for these effects (31, 36). It was postulated that activation
of certain negative regulatory factors may be involved in the
suppressive effects of cAMP (31). The presence of a cAMP-responsive
element (CREß2) on the promoter region of the RARß gene and its
involvement in the retinoic acid-dependent activation of the RARß2
promoter (41) support these ideas. Recent studies suggested that
androgen may modulate prostate cell functions through a cAMP signal
transduction pathway (42, 43), and early studies have demonstrated that
androgen stimulated cAMP in rat seminal vesicle in vitro
(44) and adenyl cyclase activity in the prostate of castrated rats
(45). It is postulated that the cAMP pathway may also be involved in
the androgen regulation of RAR expression in the prostate and seminal
vesicles. Administration of exogenous testosterone to castrated rats
might stimulate cellular cAMP, which, in turn, caused a decrease in RAR
mRNA levels in the prostate and seminal vesicles. However, whether the
cAMP-mediated pathway alone is accountable for the effects of
testosterone on renal RAR mRNA remains debatable. Previously, Huang
et al. (9) postulated that the testosterone stimulation of
testicular RAR
mRNA in the prepubertal rat may reflect a balance
between certain putative, but undefined, positive mechanisms and the
negative effects of the cAMP pathway. Whether such a positive mechanism
is also involved in the testosterone up-regulation of RAR mRNAs in the
kidney remains to be verified experimentally.
In summary, the current study demonstrated the presence of a relatively
high abundance of RAR mRNA transcripts in the prostate of adult rats
under physiological conditions, and the expression of prostatic RAR
mRNA can be modulated by testosterone. These findings and reports of
metaplasia of prostate epithelial cells during vitamin A deficiency
(46), prevention of prostate carcinogenesis by retinoic acid and its
analogs (47, 48), and retinoic acid inhibition of the androgen
regulation of cell proliferation in seminal vesicles of neonatal mice
(49) emphasize the importance of the retinoic acid/RAR pathway in the
effects of androgen on prostate physiology and pathophysiology. Further
identification of the mechanisms or factors involved in this regulation
may facilitate our understanding of the pathogenesis, and perhaps its
prevention, of prostate cancer and benign prostatic hyperplasia.
 |
Acknowledgments
|
|---|
We thank Prof. P. Chambon for his generous gift of RAR cDNAs,
and Dr. Richard Watson for critical review and suggestion in the
preparation of the manuscript.
 |
Footnotes
|
|---|
1 This work was supported in part by the C. R. Bard Endowed Fund. 
2 Current address: Huashang Hospital, Shanghai, Peoples Republic of
China. 
Received June 7, 1996.
 |
References
|
|---|
-
Coffey DS 1988 Androgen action and the sex
accessory tissues. In: Knobil E, Neill JD (eds) The Physiology of
Reproduction. Raven Press, New York, pp 10811119
-
Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM,
Higgins SJ, Sugimura Y 1987 The endocrinology and developmental
biology of the prostate. Endocr Rev 8:338362[Abstract/Free Full Text]
-
Kyprianou N, Isaacs JT 1988 Activation of
programmed cell death in the rat ventral prostate after castration.
Endocrinology 122:552562[Abstract/Free Full Text]
-
Lee C, Sensibar JA, Dudek SM, Hipakka RA, Liao S 1990 Prostatic ductal system in rats: regional variation in
morphological and functional activities. Biol Reprod 43:10791086[Abstract]
-
Catterall JF, Kontula KK, Watson CS, Seppanen PJ,
Funkenstein B, Melanitou E, Hickok NJ, Bardin CW, Janne OA 1986 Regulation of gene expression by androgens in murine kidney. Recent
Prog Horm Res 42:71109
-
Isomaa V, Pajunen AEI, Bardin CW, Janne OA 1982 Nuclear androgen receptors in the mouse kidney: validation of a new
assay. Endocrinology 111:833843[Abstract/Free Full Text]
-
Mooradian AO, Morley JE, Korenman SG 1987 Biological actions of androgens. Endocr Rev 8:128[Abstract/Free Full Text]
-
OMalley BW, Tsai MJ 1992 Molecular pathways of
steroid receptor action. Biol Reprod 46:163167[Abstract]
-
Huang HFS, Li MT, Pogach LM, Qian L 1994 Messenger
ribonucleic acid of rat testicular retinoic acid receptors:
developmental pattern, cellular distribution and testosterone effect.
Biol Reprod 51:541550[Abstract]
-
De Luca LM 1991 Retinoids and their receptors in
differentiation, embryogenesis and neoplasia. FASEB J 5:29242933[Abstract]
-
Summerbell D, Maden M 1990 Retinoic acid, a
developmental signalling molecule. Trends Neurosci 13:142147[CrossRef][Medline]
-
Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M,
Chambon P, Mark M 1994 Function of the retinoic acid receptors
(RARs) during development. II. Multiple abnormalities at various stages
of organogenesis in RAR double mutants. Development 120:27492771[Abstract]
-
Chomczynski P, Sacchi N 1987 Single step method of
mRNA isolation by acid guanidinium thiocyanate-phenol-chloroform
extraction. Anal Biochem 162:156159[Medline]
-
Aviv H, Leder P 1972 Purification of biologically
active globin messenger RNA by chromatography on oligothymidylic acid
cellulose. Proc Natl Acad Sci USA 69:14081412[Abstract/Free Full Text]
-
Sambrook J, Fritsch EF, Maniatis T 1989 Molecular
CloningA Laboratory Manual. Cold Spring Harbor Laboratory, Cold
Spring Harbor
-
Zelent A, Krust A, Petkovich M, Kastner P, Chambon
P 1989 Cloning of murine
and ß retinoic acid receptors and a
novel receptor predominatly expressed in skin. Nature 339:714717[CrossRef][Medline]
-
Krust A, Kastner P, Petkovich M, Zelent A, Chambon
P 1989 A third human retinoic acid receptor, h-RAR-
. Proc Natl
Acad Sci USA 86:53105314[Abstract/Free Full Text]
-
Huang HFS, Boccabella AV 1988 Dissociation of the
quantitative and qualititative effects of the suppression of testicular
testosterone upon spermatogenesis. Acta Endocrinol (Copenh) 118:209217[Abstract/Free Full Text]
-
Evans RM 1988 The steroid and thyroid hormone
receptor super family. Science 240:889895[Abstract/Free Full Text]
-
Mangelsdorf DJ, Kliewer SA, Kakizuka A, Umesono K, Evans
RM 1993 Retinoid receptors. Recent Prog Horm Res 48:99121
-
Chambon P 1995 The molecular and genetic dissection
of the retinoid signal pathway. Recent Prog Horm Res 50:317332
-
Petkovich M 1992 Regulation of gene expression by
vitamin A: the role of nuclear retinoic acid receptors. Annu Rev Nutr 12:443471[CrossRef][Medline]
-
Zelent A, Mendelsohn C, Kastner P, Krust A, Garnier JM,
Ruffenach F, Leroy P, Chambon P 1991 Differentially expressed
isoforms of the mouse retinoic acid receptor b are generated by usage
of two promoters and alternative splicing. EMBO J 10:7181[Medline]
-
Leroy P, Krust A, Zelent A, Mendelsohn C, Garnier JM,
Kastner P, Dierich A, Chambon P 1991 Multiforms of the mouse
retinoic acid receptor alpha are generated by alternative splicing and
differential induction by retionic aicd. EMBO J 10:5969[Medline]
-
Kastner P, Krust A, Mendelsohn C, Garnier JM, Zelent A,
Leroy P, Staub A, Chambon P 1990 Murine isoforms of retinoic acid
receptor
with specific patterns of expression. Proc Natl Acad Sci
USA 87:27002704[Abstract/Free Full Text]
-
Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub
M-P, Lemeur M, Chambon P 1993 High postnatal lethality and testis
degeneration in retinoic acid receptor
mutant mice. Proc Natl Acad
Sci USA 90:72257229[Abstract/Free Full Text]
-
Shan LX, Rodriguez MC, Janne OA 1990 Regulation of
androgen receptor protein and mRNA concentrations by androgens in rat
ventral prostate and seminal vesicles and in human hepatoma cells. Mol
Endocrinol 4:16361646[Abstract/Free Full Text]
-
Tan JA, Joseph DR, Quarmby VE, Lubahn DB, Sar M, French
FS, Wilson EM 1989 The rat androgen receptor: primary structure,
autoregulation of its messenger ribonucleic acid, and
immunocytochemical localization of the receptor protein. Mol Endocrinol 12:12761285
-
Crozat A, Palvimo JJ, Julkunen M, Janne OA 1992 Comparison of androgen regulation of ornithine decarboxylase and
S-adenosylmethionine decarboxylase gene expression in rodent kidney and
accessory sex organs. Endocrinology 130:11311144[Abstract/Free Full Text]
-
Ohno S, Stenius C, Christian L, Harris C, Ivey C 1970 More about the testosterone induction of kidney alcohol
dehydrogenase activity in the mouse. Biochem Genet 4:565577[CrossRef][Medline]
-
Hu L, Gudas LJ 1990 Cyclic AMP analogs and retinoic
acid influence the expression of retinoic acid receptor
, ß and
mRNAs in F9 teratocarcinoma cells. Mol Cell Biol 10:391396[Abstract/Free Full Text]
-
Kim KH, Griswold MD 1990 The regulation of retinoic
acid receptor mRNA levels during spermatogenesis. Mol Endocrinol 4:16791688[Abstract/Free Full Text]
-
Haq R, Pfahl M, Chytil F 1991 Retinoic acid affects
the expression of nuclear retinoic acid receptors in tissues of retinol
deficient rats. Proc Natl Acad Sci USA 88:82728276[Abstract/Free Full Text]
-
Van Pelt AMM, Van der Brink CE, De Rooij DJ, Van der
Saag PT 1992 Changes in retinoic acid receptor messenger
ribonucleic acid levels in the vitamin A deficient rat testis after
administration of retinoids. Endocrinology 131:344350[Abstract/Free Full Text]
-
de The H, Marchio A, Tiollais P, Dejean A 1989 Differential expression and ligand regulation of the retinoic acid
receptor
and ß genes. EMBO J 8:429433[Medline]
-
Martin CA, Ziegler LM, Napoli JL 1990 Retinoic
acid, dibutyryl-cAMP, and differentiation affect the expression of
retinoic acid receptors in F9 cells. Proc Natl Acad Sci USA 87:48044808[Abstract/Free Full Text]
-
Song S, Siu CH 1989 Retinoic acid regulation of the
expression of retinoic acid receptors in wild-type and mutant embryonal
carcinoma cells. FEBS Lett 256:5154[CrossRef][Medline]
-
Kruyt FAE, van der Brink CE, Defize LHK, Donath MJ,
Kastner P, Kruijer W, Chambon P, van der Saag PT 1991 Transcriptional regulation of retinoic acid receptor ß in retinoic
acid sensitive and resistant P 19 embryocarcinoma cells. Mech Dev 33:171178[CrossRef][Medline]
-
de The H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H,
Dejean A 1990 Identification of a retinoic acid responsive element
in the retinoic acid receptor ß gene. Nature 343:177180[CrossRef][Medline]
-
Hoffmann B, Lehmann JM, Zhang XK, Herrmann T, Husmann M,
Graupner G, Pfahl M 1990 A retinoic acid receptor-specific element
controls the retinoic acid receptor-beta promoter. Mol Endocrinol 4:17271736[Abstract/Free Full Text]
-
Kruyt FAE, Folkers G, van der Brink CE, van der Saag
PT 1992 A cyclic AMP response element is involved in retinoic
acid-dependent RARß2 promoter activation. Nucleic Acids Res 20:63936399[Abstract/Free Full Text]
-
Nakhla AM, Kahn MS, Rosner W 1990 Biologically
active steroids activate receptor- bound human sex hormone-binding
globulin to cause LNCaP cells to accumulate adenosine
3',5'-monophosphate. J Clin Endocrinol Metab 71:398404[Abstract/Free Full Text]
-
Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA 1992 Sex hormone-binding globulin binding to cell membranes and
generation of a second messenger. J Androl 13:101106[Free Full Text]
-
Thomas JA, Singhal RL 1973 Testosterone-stimulation
of adenyl cyclase and cyclic 3'5' adenosine
monophosphate-3H formation in rat seminal vesicles. Biochem
Pharmacol 22:507511[CrossRef][Medline]
-
Singhal RL, Parulekar MR, Vijayvargiya R, Robison
GA 1971 Metabolic control mechanism in mammalian systems:
involvement of adenosine 3',5' cyclic monophosphate in androgen action.
Biochem J 125:329342[Medline]
-
Wolbach S, Howe PR 1925 Tissue changes following
deprivation of fat soluble A vitamin. J Exp Med 42:753777[Abstract]
-
Pollard M, Luckert PH, Sporn MB 1991 Prevention of
primary prostate cancer in Lobund Wistar rats by
N-(4-hydroxyphenyl retinamide). Cancer Res 51:36103611[Abstract/Free Full Text]
-
Lasnitzki I 1955 The influence of a
hypervitaminosis on the effect of 20-methylcholanthrene on mouse
prostate gland grown in vitro. Br J Cancer 9:434441[Medline]
-
Tanji N, Yokoyama M, Takeuchi M, Terada N, Dahiya R,
Cunha G 1996 Inhibitory effects of retinoic acids on
androgen-dependent development of neonatal mouse seminal vesicles
in vitro. Endocrinology 137:28872895[Abstract]
This article has been cited by other articles:

|
 |

|
 |
 
F. Richter, A. Joyce, F. Fromowitz, S. Wang, J. Watson, R. Watson, R. J. Irwin Jr, and H. F. S. Huang
Immunohistochemical Localization of the Retinoic Acid Receptors in Human Prostate
J Androl,
November 1, 2002;
23(6):
830 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Prins, W. Y. Chang, Y. Wang, and R. B. van Breemen
Retinoic Acid Receptors and Retinoids Are Up-Regulated in the Developing and Adult Rat Prostate by Neonatal Estrogen Exposure
Endocrinology,
September 1, 2002;
143(9):
3628 - 3640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. S. Huang, M.-T. Li, W. Giglio, R. Anesetti, J. E. Ottenweller, and L. M. Pogach
The Detrimental Effects of Spinal Cord Injury on Spermatogenesis in the Rat Is Partially Reversed by Testosterone, but Enhanced by Follicle- Stimulating Hormone
Endocrinology,
March 1, 1999;
140(3):
1349 - 1355.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Su, X. Chai, B. Kahn, and J. L. Napoli
cDNA Cloning, Tissue Distribution, and Substrate Characteristics of a cis-Retinol/3alpha -Hydroxysterol Short-chain Dehydrogenase Isozyme
J. Biol. Chem.,
July 10, 1998;
273(28):
17910 - 17916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chai, Y. Zhai, and J. L. Napoli
cDNA Cloning and Characterization of a cis-Retinol/3alpha -Hydroxysterol Short-chain Dehydrogenase
J. Biol. Chem.,
December 26, 1997;
272(52):
33125 - 33131.
[Abstract]
[Full Text]
[PDF]
|
 |
|